The Wilm's tumor suppressor gene, wt1, is expressed in a very de®ned spatial-temporal fashion and plays a key role in development of the urogenital system. Transacting factors governing wt1 expression are poorly de®ned. The presence of putative kB binding sites within the wt1 gene prompted us to investigate whether members of the NF-kB/Rel family of transcription factors are involved in regulating wt1 expression. In transient transfection assays, ectopic expression of p50 and p65 subunits of NF-kB stimulated wt1 promoter activity 10 ± 30-fold. Deletion mutagenesis revealed that NF-kB responsiveness is mediated by a short DNA fragment located within promoter proximal sequences of the major transcription start site. Two kB-binding sites are present in this region and form speci®c complexes with puri®ed NF-kB proteins, as revealed by electrophoretic mobility gel shift assays. Ectopic expression of p50 and p65 resulted in increased transcription of the endogenous wt1 gene, as revealed by nuclear run-on experiments. Taken together, these results indicate that members of the NF-kB/Rel family are important for activating expression of wt1 and reside upstream of the regulatory cascade leading to wt1 activation.
Introduction
Wilms' tumor (WT) or nephroblastoma is a renal malignancy of complex pathology that aects children, usually before the age of 5 years and with an incidence of *1/10 000 (Matsunaga, 1981) . The tumor is thought to originate from metanephric blastemal cells which have failed to undergo normal dierentiation, and instead, undergo neoplastic transformation with subsequent progression to tumor formation. Most cases of WTs are unilateral and sporadic, however, a small number are bilateral and hereditary (5 ± 10%) (Matsunaga, 1981) . Mutations in the wt1 Wilms' tumor suppressor gene, residing at chromosome 11p13, are associated with initiation of this malignancy (Haber et al., 1991; .
The wt1 encodes a zinc ®nger protein of the Cys 2 -His 2 family and consists of 10 exons which are alternatively spliced to produce four distinct mRNA species. The ®rst alternatively spliced exon (#5) results in the inclusion or exclusion of 17 amino acids from the glutamine/proline rich amino (N-) terminus of WT1, whereas the second alternatively spliced exon results in the insertion of three amino acids, KTS, between the third and the fourth zinc ®ngers (for a review, see Reddy and Licht, 1996) . WT1 has several key structural features of a transcription factor such as nuclear localization, a proline/glutamine N-terminal rich region, and a DNA-binding domain consisting of four zinc ®ngers. Three of the four zinc ®ngers (II, III and IV) share extensive homology with those of the early growth response (EGR) family of transcription factors and consequently, WT1 can bind to, and regulate, the expression of numerous genes through the GC-rich egr-1 consensus binding site (5'GCGGGGGCG3'), as well as through a TC-rich site (5'TCC3') n (Rauscher et al., 1990; Wang et al, 1993) . Genes harboring these elements are often involved in the regulation of cellular proliferation and dierentiation (Reddy and Licht, 1996) .
The wt1 gene is expressed in a very de®ned spatialtemporal manner being expressed mainly in the kidney, gonads, spleen, and mesothelium (Pritchard-Jones et al., 1990; Pelletier et al., 1991c) . In the developing kidney, the gene is expressed during the mesenchymal to epithelial transition, suggesting that wt1 plays a critical role during this developmental step (PritchardJones et al., 1990; Pelletier et al., 1991c) . Consistent with this idea is the failure of this system to develop in wt1-null mice (Kreidberg et al., 1993) , as well as in many individuals with wt1 germline mutations (Pelletier et al., 1991a,b) . Insights into the regulation of wt1 expression are thus essential for understanding the role that WT1 plays during normal and abnormal development. The upstream regulatory regions of the human and mouse wt1 genes are GC-rich and do not contain a CAAT or a TATA box (Pelletier et al., 1991c , Homann et al., 1993 . Several ubiquitous and tissue-speci®c transcription factors, such as Sp1, WT1, GATA-1, Pax-2 and Pax-8, have been shown to modulate the expression of the wt1 promoter in transient transfection assays (Rupprecht et al., 1994; Wu et al., 1995; Cohen et al., 1997) .
The NF-kB/Rel family of transcription factors play a key regulatory role in the expression of a variety of genes involved in several biological processes such as immune or in¯ammatory responses, growth, differentiation, and development (Baldwin, 1996; Verma et al., 1995) . Members of this family are characterized by the presence of a highly conserved domain of 300 amino acids at the N-terminal region called the Rel homology domain (RHD) and consisting of a DNA-binding motif, a dimerization domain, and a nuclear localization signal. The prototype of this family, referred to as NF-kB, consists of two subunits called p50 (NF-kB1) and p65 (RelA) which form homo-and heterodimers.
Members of the NF-kB transcription factor family have been identi®ed in various organisms, ranging from¯ies to mammals (Baldwin, 1996; Verma et al., 1995) . In mammals, other members of this family include p52 (NF-kB2), rel B, and the proto-oncogene c-Rel. In most cells, NF-kB proteins are sequestered in the cytoplasm in a latent form by virtue of their association with the inhibitory protein, IkB. However, stimulation of these cells by a wide variety of inducers including cytokines such as TNF-a and IL-1, mitogens, and DNA damaging agents, leads to the rapid phosphorylation and degradation of IkB, thus allowing nuclear translocation of NF-kB and modulation of the appropriate target genes (Beg et al., 1993; Brown et al., 1993; Sun et al., 1993) .
The presence of putative kB binding sites (5'GGGRNNYYCC3') in the human and murine wt1 promoter suggested to us that members of the NF-kB family of transcription factors may be involved in regulating wt1 expression. In this report, we demonstrate that overexpression of p50 and p65 strongly transactivate the murine wt1 promoter. Likewise, ectopic expression of p50 and p65 leads to stimulation of transcription of the endogenous wt1 gene, as revealed by nuclear run-on experiments.
Results
The murine wt1 promoter contains three transcription start sites (Pelletier et al., 1991c) . Of these, a major start site is conserved between human and mouse promoters, and in the mouse occurs approximately 341 nucleotides downstream of the ®rst start site. Visual inspection of the murine wt1 5' regulatory sequences lead us to identify two potential decanucleotide kB-binding sites present in the proximal promoter region: kB.d (+376GGGGCTCTCC+385) and kB.u (+326GG-GGGCAGCC+335) (Figure 1a ). In the human wt1 gene, the sequence of the kB.d site is conserved, whereas there is a single nucleotide dierence in the kB.u site (5'GAGGGCAGCC3') (Homann et al., 1993) .
Transactivation of the wt1 promoter by ectopic expression of NFkB
Given that kB elements mediate activation by the large family of NF-kB/Rel transcription factors (Baldwin, 1996) , we tested whether members of NF-kB could modulate activity of the wt1 promoter. To this end, expression vectors for p50 (NF-kB1) and p65 (relA) were co-transfected, in conjunction with SalI/CAT, in K562, 293, and NIH3T3 cells. As shown in Figure 1b and c, coexpression of p50 and p65 reproducibly stimulated SalI-CAT expression 15 ± 20-fold relative to pCAT. The fold activation observed with SalI-CAT was as strong as, if not better, than that observed with the positive control IgkB-TATA-CAT, containing immunoglobulin kB enhancer sites upstream of the bglobin TATA box (Figure 1b, c) . Consistent with the speci®city of the observed response being dependent on expression of NF-kB, IgmkB-TATA-CAT, which contains a mutated kB binding site, did not respond to NF-kB (Figure 1b, c) .
These results indicate that p50 and p65 are capable of activating transcription of the wt1 promoter through speci®c cis-acting elements. In order to de®ne these, we generated a series of deletion mutants within the wt1 promoter and examined the ability of p50 and p65 to activate wt1/CAT expression in K562 cells. All promoter constructs contained the major wt1 transcription initiation site ( Figure 1a ). In general, the transcriptional response of the deletion mutants HindIII-CAT, SpeI-CAT, EcoRI-CAT, +23-CAT, +34-CAT, +118-CAT, and +261-CAT were similar ( Figure 2b , 20 ± 60-fold activation in the presence of NF-kB). The highest response obtained was with +261-CAT (460-fold). Only construct +261/+360-CAT showed a transactivation response lower (only ®vefold) than the parental plasmid, SalI-CAT, indicating that this region does not confer full responsiveness to NF-kB ( Figure 2b ). These results suggest that the region mediating NF-kB responsiveness is located within a 173 bp region between nucleotides +318 and +491 (relative to the ®rst transcription initiation site). Similar results were also obtained in 293 and NIH3T3 cells (data not shown).
Identi®cation of NF-kB responsive elements
To identify the NF-kB responsive elements residing between nucleotides +318 and +491 of the wt1 promoter, we transferred a wt1 fragment spanning nucleotides +261 to +491 into a TATA-less, enhancer-less, version of pJFCAT1 ( Figure 3a ). Sitedirected mutagenesis was then performed to eliminate each kB site identi®ed within the murine wt1 promoter by visual inspection (Figure 1a ). The NF-kB responsiveness of these reporters in K562 cells is shown in Figure 3b . Construct +261/pJFCAT1 was still kB responsive, although the fold activation was not as strong as with the enhancer containing expression vector, +261-CAT (compare the response in Figure 3b to that obtained with +261-CAT in Figure 2b ). Sitedirected or deletion mutagenesis of the kB.d site (+261-mkB.d/pJFCAT1 and +261-DkB.d/pJFCAT1, respectively) essentially abolished NF-kB responsiveness, whereas mutagenesis of the kB.u site had no eect ( Figure 3b ). These experiments identify the kB.d site as the functional kB responsive element.
Interaction of p50 and p65 with kB.d
To assess whether kB.d could interact directly with NF-kB, we performed a series of mobility shift assays using oligonucleotides containing either kB.u or kB.d as probes in the presence of puri®ed GST-P50 and GST-p65 proteins (Figure 4 ). An oligonucleotide containing the immunoglobulin kB enhancer served as a speci®c competitor and an oligonucleotide containing a mutated copy of the Ig kB enhancer served as a negative control for non-speci®c competition. An oligonucleotide containing the kB.d element formed a single complex with NF-kB ( Figure 4 , lane 1). This complex is speci®c since it can be competed with excess of authentic wild-type oligonucleotide (compare lane 2 to 1) or an oligonucleotide containing an Ig kB site (compare lane 4 to 1). Oligonucleotides with mutated kB sites were not capable of competing NF-kB/kB.d complexes (compare lanes 3 and 5 to 1). An oligonucleotide containing the kB.u element was also capable of forming a speci®c complex with p50 Open boxes signify response of each reporter to CMV/D, whereas blackened boxes signify responses to p50 and p65. CAT activity was normalized to b-galactosidase and the fold activation was calculated by expressing the conversion value obtained for each reporter in the presence of NF-kB, to the CAT conversion value obtained for that same reporter in the absence of NF-kB, which was set at 1 and p65 (lanes 6 ± 10). However, probe titration experiments indicated that the eciency of complex formation was at least 20-fold lower than with kB.d (MD, data not shown). These results are consistent with the idea that kB.d mediates the majority of kBresponsiveness described above.
Activation of the endogenous wt1 promoter by NF-kB
To investigate whether ectopic expression of NF-kB could modulate the activity of the endogenous wt1 promoter, we performed nuclear run-on transcription analysis in NIH3T3. In this experiment, cells were transiently transfected with p65 alone or, p50 and p65, and nuclei were isolated and analysed for the expression of wt1. As shown in Figure 5 , expression of p65 alone did not aect wt1 expression. Expression of NF-kB in NIH3T3 cells produced a 3 ± 4-fold increase in the transcription rate of wt1 ( Figure 5 ). Control hybridizations with RSV-LacZ and GAPDH indicated that this increase was not due to dierences in transfection eciency. Hybridization to p50 cDNA indicated that increased amounts of p50 transcripts were generated in response to increase plasmid levels in the transfection mixture, indicating the linearity of the assay. Taken together, these results suggest that expression from the endogenous wt1 promoter can be positively modulated by the p50 and p65 subunits of NF-kB.
Discussion
The analysis described in this report indicates that the wt1 promoter can be strongly transactivated by p50 and p65 subunits of NF-kB, and that this eect is mediated by a binding site positioned immediately downstream of the major transcription start site. This Reporter plasmids used are indicated below the bar graphs. CAT values were normalized relative to b-galactosidase activity. The absence or presence of p50 and p65 expression vectors in the transfection mixture is symbolized by an open or darkened box, respectively. Each experiment has been reproduced a minimum of three times and is expressed relative to that obtained with CMV/D and +261/pJFCAT1, which was set at 1 site speci®cally interacts with puri®ed p50 and p65 as assessed by EMSA and conforms to the kB consensus sequence (5'GGGRNNYYCC3'). In contrast, the kB.u element shares 80% similarity with the kB consensus sequence, cannot eciently form a complex with p50 and p65, and is not capable of mediating a kB response when placed in a heterologous context. This site, unlike the kB.d site, is not conserved between murine and human wt1 5' regulatory sequences. We have also demonstrated the in vivo responsiveness of the endogenous wt1 promoter to exogenously added p50 and p65, utilizing nuclear run-on assays ( Figure 5 ). The intensity of the response obtained in vivo, is likely to be an underestimation, given that the nuclear run-ons were performed on nuclei from transiently transfected cells and that the wt1 gene is usually not transcriptionally active in NIH3T3 cells. Our results do not allow us to infer conclusions regarding the role of additional kB sites, not identi®ed in the current study, on in vivo wt1 regulation.
The wt1 gene shows a very de®ned spatial and temporal expression in the developing urogenital system, and is essential for mesenchymal-epithelial transitions in this system (Pritchard-Jones et al., 1990; Pelletier et al., 1991c) . In addition, wt1 is also expressed in the hematopoietic system, although its role in this system is not de®ned (Reddy and Licht, 1996) . Our studies, coupled with those of other groups, indicate that regulation of the wt1 promoter is complex. Two developmentally regulated paired-box family members, Pax-2 and Pax-8, have been shown to activate wt1 expression through a 38 bp conserved motif present upstream of the ®rst transcription start site . In addition, multiple sites for Sp1 are present throughout the wt1 promoter, and this factor has been shown to transactivate wt1 expression (Homan et al., 1993; Cohen et al., 1997) . The wt1 promoter is also responsive to its own gene product, and this is thought to down-regulate the wt1 response in vivo (Rupprecht et al., 1994) . A hematopoietic-speci®c enhancer is located in the 3' end of the human wt1 gene, greater than 50 kilobases (kb) downstream from the promoter (Fraizer et al., 1994) . The hematopoieticspeci®c transcription factor, GATA-1, has been shown to transactivate wt1 expression through this enhancer, implying that GATA-1 plays a role in the regulation of wt1 during hematopoiesis (Wu et al., 1995) .
It is unlikely that NF-kB complex expression is required for initiation of wt1 expression in the developing urogenital system. Unlike wt1 null mice which show severe abnormalities of the heart, diaphragm, and urogenital system (Kreidberg et al., 1993) , p50 null mice show no development abnormalities, although they exhibit multiple defects in speci®c and non-speci®c immune responses involving B lymphocytes . Mice lacking p65 are embryonic lethal at 15 ± 16 days gestation and exhibit massive degeneration of the liver by apoptosis (Beg et al., 1995) , but no reported renal or gonadal abnormalities. It is possible that other members of the NF-kB/Rel family can compensate for p50 or p65 function although in our hands, c-rel was unable to activate wt1 expression (MD, data not shown). Alternatively, NF-kB regulation of wt1 expression may be primarily restricted to the hematopoietic system, in which case some the defects observed in p50 null mice could be due to depressed levels of WT1.
Studies on the regulation of wt1 gene expression has been performed in several human hematopoeitic cell lines. Several investigators have noticed a marked downregulation of wt1 in K562 and HL60 cells during dierentiation induced by TPA (Phelan et al., 1994; Sekiya et al., 1994) . Interestingly, stimulation of HL60 cells by TPA interferes with NF-kB activity (Hohmann et al., 1992) . Our studies have not addressed the possible regulation of the human wt1 gene by NF-kB, although sequence comparison of the wt1 5' regulatory sequences between human and murine promoters Following hybridization and washing, the blot was exposed to Kodak XOmat ®lm for 48 h at 7708C with an intensifying screen revealed that kB.d element is conserved. Moreover, we note the presence of 2 kB-like sequences in the human promoter, arranged as a tandem repeat between nucleotides 7189 and 7166, upstream of the ®rst transcription initiation site (5'GGGTGTCTCCGAGA GGGACGCTCC3', kB sites are underlined) (Hofmann et al., 1993) . This organization is similar to the 2 kB elements found in the HIV-1 LTR where both sites have been shown to be important for NF-kB activation (Nabel and Baltimore, 1987) . Whether the kB sites present in the human wt1 promoter act in similar fashion remains to be established, as does the potential relationship between antagonism of NF-kB in differentiating HL60 cells and wt1 downregulation. The data presented herein raise several questions about the signi®cance of wt1 activation by NF-kB and whether inducers of NF-kB can modulate the expression of wt1 gene. We have tested whether the cytokine TNF-a, a potent inducer of NF-kB, can activate wt1 gene expression. Although we have failed to detect an eect of TNF-a on transcription of the endogenous wt1 promoter in 293, K562, and NIH3T3 cells, we did observe a 4 ± 5-fold stimulation of +261-CAT expression in these same cells following treatment with TNF-a (MD, data not shown). We note that the kB response obtained with +261-CAT however, was dependent on the presence of an SV40 enhancer element within the parental plasmid, suggesting possible synergy between NF-kB and trans-acting factor(s) on the enhancer (MD, data not shown). Whether a similar situation is also occurring in vivo at the wt1 gene remains to be determined. The reasons for the discrepancy between the in vivo and in vitro experiments with TNF-a are not clear, but may relate to the chromatin context of the endogenous wt1 gene in our tissue culture assays, which prevents activation by endogenous levels of NF-kB.
It is also possible that NF-kB complexes are involved in sustaining the wt1 activation response, possibly involving synergy with other transcription factors. Such cooperativity has recently been described by Perkins et al. (1993) , who demonstrated that activation of the HIV-1 LTR depends on an interaction between p65 and Sp-1. Transactivation of the wt1 promoter is also positively regulated by Sp-1 (Cohen et al., 1997; Homan et al., 1993) . Whether transactivation of wt1 by NF-kB complexes is Sp-1 dependent remains to be determined. In summary, p50 and p65 subunits of NF-kB are potent inducers of wt1 activity. The role that such a response plays in regulating wt1 activity, either in the urogenital and/or hematopoeitic system, remains to elucidated.
Materials and methods

Plasmid constructs
The wt1-chloramphenicol acetyl transferase (CAT) reporter plasmids, SalI-CAT, SpeI-CAT, HindIII-CAT and EcoRI-CAT have been previously described and contain varying portions of the wt1 promoter fused to the CAT gene (Figure 1a ) . The reporter plasmids +23-CAT, +34-CAT, +118-CAT, +261-CAT, +318-CAT, and +261/+360-CAT were generated by PCR-mediated mutagenesis using SpeI-CAT plasmid as template with the following sense oligonucleotides: +23; 5' ATAAGCTTGTCGACACACCGAGGGGACTCATTA-C3', +34; 5'ATAAGCTTGT CGACCTTACCTAGACGC-CTTGCC3', +118; 5'ATAAGCTTGTCGACGCTGAGA-GCACGTGGCCG3', +261; 5'ATAAGCTTGTCGACG-CCGAGCATCCTGGCTCC3', +318; 5'ATAAGCTTT-GGGAAGCTGGGGGC3' respectively, in conjunction with the antisense oligonucleotide: 5'GGAAGATCTTCC-GGTTCCTGGGCTGCCGTCC3'. The same strategy was used to generate +261/+360-CAT, by using the +261 sense oligonucleotide (indicated above) and the +360 antisense oligonucleotide; 5'GGAAGATCTTGAACTCC-TTACCCCAGTGCT3'. The resulting products were digested with HindIII and BglII and inserted into the HindIII-BamHI sites of pCAT-Enhancer . The sequence integrity of each clone was directly con®rmed by sequencing (Sanger et al, 1977) .
Plasmid constructs carrying only the proximal region of the wt1 promoter (+261/+491) driving expression of the CAT reporter gene, in an enhancer-less context, were generated by cloning the +261/+491 PCR product into the SalI-BglII sites of pJFCAT1 (Fridovich-Keil et al., 1991) . Plasmids +261-mkB.d/pJFCAT1 and +261-mkB.u/pJFCAT1 were made by overlap PCR mediated mutagenesis and changed the upstream (5'GGGGCA3') or downstream (5'GGGGCT3') kB core sequences to an XbaI site (5'TCTAGA3'). The kB.d sequence was deleted by PCR using primers to loop out the kB.d site (along with¯anking sequence [5'AGGCAGCGCCCACACCCGGGGCTCTCCG-CAACCC3']) to generate plasmid +261-D kB.d/pJFCAT1. Plasmids CMV/p50 (NF-kB1) and CMV/p65 (relA) have been previously described (Hiscott et al., 1993) .
Cell culture, transfections, and CAT assay
Two hundred and ninety-three kidney cells, NIH3T3 ®broblast, and erythroleukemic K562 cells, were grown at 378C in a-MEM, DMEM, and RPMI 1640, respectively. Media was supplemented with 10% heat-inactivated fetal calf serum, penicillin, and streptomycin. For transactivation assays, K562, 293, and NIH3T3 cells were transfected with 10 mg of reporter plasmid, and 1.15 mg of each CMV/ p50 (NF-kB1) and CMV/p65 (relA) expression vector, or 2.3 mg of the empty expression vector, CMV/D . Transfection eciency was controlled by cotransfecting with 3 mg of pRSV-lacZ. Thirty-six to fortyfour hours post-transfection, cells were harvested and assayed for b-galactosidase and CAT activity (Gorman, 1985) . Regions of the TLC plate containing 14 C-acetylated and unacetylated chloramphenicol were isolated by scraping and were quantitated by counting in a liquid scintillation counter.
Electrophoretic mobility shift assays (EMSA)
The p50 and p65 subunits were expressed as GST-fusion proteins and puri®ed from bacterial lysates by anity chromatography using glutathione-Sepharose 4B beads as recommended by the manufacturer (Pharmacia). Twenty®ve nanograms of each puri®ed protein was used in EMSA with oligonucleotides derived from the murine wt1 promoter and consisted of either downstream [kB.d (+376/+385)] or upstream [kB.u (+326/+335)] sequences. Probes were labeled by ®lling in the ends with the Klenow fragment of DNA polymerase I in the presence of a-[ 32 P]dCTP (43000 Ci/mmol; Dupont-New England Nuclear). EMSA were performed essentially as described previously . In competition experiments, proteins were preincubated with an excess of unlabeled wild-type (kB.d, kB.u or IgkB) or mutated (mkB.d, mkB.u or IgmkB) oligonucleotides for 15 min, prior to addition of labeled probe. The following oligonucleotides were used in competition assays: kB.d
